Effectiveness of the TYPHIBEV® (Vi-CRM197 conjugate) vaccine introduction in Nepal: A test-negative, case-control study

The findings indicate that TYPHIBEV® was highly effective in preventing typhoid fever over a 30-month follow-up period following national introduction, with effectiveness estimates comparable to those observed for Typbar-TCV®.